These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23637119)

  • 1. β-Adrenergic blockade in cardiovascular disease.
    Frishman WH
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):310-9. PubMed ID: 23637119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Adrenergic blockers: a 50-year historical perspective.
    Frishman WH
    Am J Ther; 2008; 15(6):565-76. PubMed ID: 19127141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
    Mehvar R; Brocks DR
    J Pharm Pharm Sci; 2001; 4(2):185-200. PubMed ID: 11466176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative properties of various beta-blockers, with an outlook to the future.
    van Zwieten PA
    Clin Physiol Biochem; 1990; 8 Suppl 2():18-27. PubMed ID: 1982758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of beta-blockers as a cornerstone of cardiovascular therapy.
    Hollenberg NK
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):165S-168S. PubMed ID: 16373194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New perspectives in cardiopulmonary therapeutics: receptor-selective adrenergic drugs.
    Adams HR
    J Am Vet Med Assoc; 1984 Nov; 185(9):966-74. PubMed ID: 6150925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockage therapy and cardiovascular disease. Past, present, and future.
    Prichard BN
    Postgrad Med; 1988 Feb; Spec No():8-18. PubMed ID: 2894664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebivolol: the somewhat-different beta-adrenergic receptor blocker.
    Münzel T; Gori T
    J Am Coll Cardiol; 2009 Oct; 54(16):1491-9. PubMed ID: 19815121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in betablocking drugs in cardiovascular therapy.
    Iisalo E; Heikkilä J
    Ann Clin Res; 1988; 20(5):324-33. PubMed ID: 2905877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide mechanisms of nebivolol.
    Maffei A; Lembo G
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-short-acting beta-adrenergic blockers.
    Frishman WH; Murthy S; Strom JA
    Med Clin North Am; 1988 Mar; 72(2):359-72. PubMed ID: 2894487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic blocking agents in the treatment of hypertension. Choices based on pharmacological properties and patient characteristics.
    Wallin JD; Shah SV
    Arch Intern Med; 1987 Apr; 147(4):654-9. PubMed ID: 2881524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic blockade. An update.
    Frishman WH; Teicher M
    Cardiology; 1985; 72(5-6):280-96. PubMed ID: 2866839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indications spectrum for beta-1-selective adrenergic receptor blockers].
    Dotzer F; Gromer H
    Fortschr Med; 1993 Aug; 111(24):382-4. PubMed ID: 8104853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving mechanisms of action of beta blockers: focus on nebivolol.
    Mason RP; Giles TD; Sowers JR
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):123-8. PubMed ID: 19528811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].
    Mio Y
    Masui; 2006 Jul; 55(7):841-8. PubMed ID: 16856544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I; Edes I
    Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of carvedilol controlled-release in cardiovascular disease.
    Fonarow GC
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):483-98. PubMed ID: 19419256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.